DJIA 16,987.51 -61.49 -0.36%
NASDAQ 4,567.60 -24.21 -0.53%
S&P 500 1,985.54 -11.91 -0.60%
market minute promo

ImmunoGen (NASDAQ: IMGN)

11.41 -0.27 (-2.31%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IMGN $11.41 -2.31%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.70
Previous Close $11.68
Daily Range $11.30 - $11.75
52-Week Range $10.28 - $18.22
Market Cap $980.2M
P/E Ratio -14.07
Dividend (Yield) $0.00 (0.0%)
Volume 532,405
Average Daily Volume 749,633
Current FY EPS -$0.70





ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website:

News & Commentary

3 Beaten-Down Stocks Worth Buying

It isn't easy to find value in this market, but these three stocks could be making a strong case to rebound from their recent lows.

ETF Rebalance Could Make 5 Biotech Stocks Shoot Higher

Trade-Ideas: Immunogen (IMGN) Is Today's Strong On High Relative Volume Stock

Why ImmunoGen (IMGN) Could Be Positioned for a Surge? - Tale of the Tape

Risk And Reward Seem Pretty Balanced At Seattle Genetics

ImmunoGen Q4 Loss Narrower than Expected, Provides Guidance - Analyst Blog

ImmunoGen's (IMGN) CEO Daniel Junius on Q4 2014 Results - Earnings Call Transcript

Q4 2014 Immunogen Inc Earnings Conference Call (Webcast)

Why ImmunoGen (IMGN) Might Surprise This Earnings Season - Tale of the Tape

Why ImmunoGen (IMGN) Might Surprise This Earnings Season - Tale of the Tape

Will ImmunoGen's Q4 Earnings Disappoint Again?

See More IMGN News...

IMGN's Top Competitors

IMGN $11.41 (-2.31%)
Current stock: IMGN
AMGN $137.89 (-0.77%)
Current stock: AMGN
GILD $103.66 (-2.57%)
Current stock: GILD
BIIB $323.39 (-1.14%)
Current stock: BIIB